Sorrento Therapeutics
SRNEQ
$0.03000
Share price
3.45%
Change (1 day)
-87.50%
Change (1 year)
Categories
P/S ratio for Sorrento Therapeutics (SRNEQ)
P/S ratio as of May 2024 (TTM): 0.2573
According to Sorrento Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.257327. At the end of 2023 the company had a P/S ratio of 3.07.
P/S ratio history for Sorrento Therapeutics from 2010 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.07 | -53.84% |
| 2022 | 6.65 | -75.94% |
| 2021 | 27.6 | -41.16% |
| 2020 | 47.0 | 160.4% |
| 2019 | 18.0 | 30.3% |
| 2018 | 13.8 | 569.2% |
| 2017 | 2.07 | -94.06% |
| 2016 | 34.8 | -51.41% |
| 2015 | 71.7 | -24.76% |
| 2014 | 95.3 | -76.52% |
| 2013 | 406 | 426.18% |
| 2012 | 77.1 | -18.32% |
| 2011 | 94.4 | -57.17% |
| 2010 | 220 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Karyopharm Therapeutics
KPTI | 0.8135 | 216.13% | 🇺🇸 USA |
 Exelixis EXEL | 3.41 | 1,223.47% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |